Showing results (191-200 of 203) with videos related to
Sort By:
Pageof 21
Nanotechnology|April 28, 2015
Atomic switch networks-nanoarchitectonic design of a complex system for natural computingE C Demis, R Aguilera, H O Sillin, et al.Transfusion|March 1, 1993
A flow cytometric method for counting very low levels of white cells in blood and blood componentsM Vachula, S J Simpson, J A Martinson, et al.Leukemia|July 4, 2008
Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myelomaI Breitkreutz, M S Raab, S Vallet, et al.International Journal of Clinical Practice|April 20, 2012
Sitagliptin add-on to low dosage sulphonylureas: efficacy and safety of combination therapy on glycaemic control and insulin secretion capacity in type 2 diabetesS-I Harashima, M Ogura, D Tanaka, et al.Neuroscience|February 1, 2003
Protective effect of apolipoprotein E-mimetic peptides on N-methyl-D-aspartate excitotoxicity in primary rat neuronal-glial cell culturesM Aono, E R Bennett, K S Kim, et al.Leukemia|April 17, 2009
Ascorbic acid inhibits antitumor activity of bortezomib in vivoG Perrone, T Hideshima, H Ikeda, et al.Microscopy (Oxford, England)|November 1, 2014
X-ray STM: Nanoscale elemental analysis & Observation of atomic trackAkira Saito, Y Furudate, Y Kusui, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 14, 2012
Efficacy and safety of switching from basal insulin to sitagliptin in Japanese type 2 diabetes patientsS-I Harashima, D Tanaka, S Yamane, et al.Journal of Neurotrauma|July 5, 2001
Extracellular superoxide dismutase overexpression improves behavioral outcome from closed head injury in the mouseJ A Pineda, M Aono, H Sheng, et al.Leukemia|February 3, 2007
Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathwayH Yasui, T Hideshima, H Ikeda, et al.Pageof 21